Clinical Trials Market

Clinical Trials Market

Category : Healthcare & Life Sciences Reports | Delivery Format : PDF,PPT | Publisher: Reports and Insights | Pages : 205

To learn more about this report, request a free sample copy

Clinical Trials Market Overview

The report is titled as ‘Clinical Trials Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the clinical trials market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market. Clinical trials market is expected to grow with significant rate in the near future.

The clinical trials market in 2020 is accounted for more than US$ 45.3 Bn and expected to reach at a value of US$ 73.7 Bn by 2028 with a significant CAGR of 6.3%.

Clinical Trials Introduction

Healthy margins and little risk associated with manufacturing operations, majority of pharmaceutical companies opt to keep their manufacturing activities close to domestic market. However, financial pressures and shrinking R&D budgets have made pharmaceutical companies to go offshore for clinical trials. Thus outsourcing of clinical trials is emerging as a prominent trend in global market. Clinical trials account for two-third of the total cost of drug development. The leading pharmaceutical companies conduct their clinical trials in familiar territory, with most of trials taking place in the U.S. and Europe.  

Clinical Trials Market Dynamics

Unprecedented growth in pipeline activities of global pharmaceutical and biopharmaceutical companies drives the growth of global clinical trials market. Outsourcing of clinical trials is growing at the rapid pace which is expected to further drive the growth of global clinical trials market.

Expanding R&D budget is another important factor driving growth of global clinical trials market. Introduction of clear regulatory pathways in many developing countries such as India, China, and Turkey etc. is attracting global pharmaceutical companies to launch their drugs in these regions. Thus companies are conducting multiple clinical trials in several territories at the same time.

However, risks associated with failure of clinical trials discourage the companies from developing new drug, which is the limiting factor for global clinical trials market.

Clinical Trials Market Key Players

Some of the key players identified in global clinical trials market are Quintiles IMS, Paraxel International Corporation, ICON PLC, Chiltern International Ltd., BIOCLINICA, MEDIDATA, BIO – OPTRONICS, SPARTA SYSTEMS etc. among others.

Clinical Trials Market Segmentation

The global clinical trials market is segmented on the basis of phase, indication, and region. By phase, global market is segmented in to phase 1, phase 2, phase 3 and phase 4. On the basis of indication, the global clinical trials market is segmented into oncology, pain management, autoimmune diseases, CNS diseases, obesity, diabetes, cardiovascular diseases and others.

Clinical Trials Market Regional Segmentation Overview

On the basis of region, the global clinical trials market is segmented into six regions namely North America, Latin America, Asia Pacific, Europe, Middle East, and Africa.

North America clinical trials market is expected to be the most dominating market throughout the forecast period due to presence of strong pharmaceutical companies. Asia Pacific region is expected to witness unprecedented growth. India and China are emerging as a choice of clinical trial destinations for many pharmaceutical companies.

Over the past decade, South Africa has become an important destination for many international pharmaceutical companies looking to carry out clinical trials due to low cost resources.

MMC Overview on Clinical Trials Market Report

The non-identical approach of Reports and Insights stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.

A research report on the Clinical Trials market by Reports and Insights is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market.

Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth includes (but not restricted to):

New product designs and launches

Current product compliance

Reimbursement

Concerns for use of Clinical Trials products

Advantages of Clinical Trials

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.

A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.


To learn more about this report, request a free sample copy


1.    Global Clinical Trials Market Report Overview

1.1.    Introduction

1.2.    Report Description

1.3.    Methodology

2.    Global Clinical Trials Market Overview

2.1.    Introduction

2.1.1.    Introduction

2.1.2.    Market Taxonomy

2.2.    Executive Summary

2.3.    Global Clinical Trials Market Snapshot

2.4.    Global Clinical Trials Market Size and Forecast, 2020–2028

2.4.1.    Introduction

2.4.2.    Market Value Forecast and Annual Growth Rate (AGR) Comparison (2020–2028)

2.5.    Global Clinical Trials Market Dynamics

2.5.1.    Drivers

2.5.2.    Restraints

2.5.3.    Opportunity

2.5.4.    Trends

2.6.    Key Regulations

2.7.    Porter’s Five Forces Model

3.    Global Clinical Trials Market, By Phase

3.1.    Introduction

3.1.1.    Annual Growth Rate Comparison, By Phase

3.1.2.    BPS Analysis, By Phase

3.2.    Market Revenue (US$Mn) Forecast, By Phase

3.2.1.    Phase 1

3.2.2.    Phase 2

3.2.3.    Phase 3

3.2.4.    Phase 4

3.3.    Global Clinical Trials Market Attractiveness Index, By Phase

4.    Global Clinical Trials Market, By Indication

4.1.    Introduction

4.1.1.    Annual Growth Rate Comparison, By Indication

4.1.2.    BPS Analysis, By Indication

4.2.    Market Revenue (US$Mn) Forecast, By Indication

4.2.1.    Oncology

4.2.2.    Pain Management

4.2.3.    Autoimmune Diseases

4.2.4.    CNS Diseases

4.2.5.    Obesity

4.2.6.    Diabetes

4.2.7.    Cardiovascular Diseases

4.2.8.    Others

4.3.    Global Clinical Trials Market Attractiveness Index, By Indication

5.    Global Clinical Trials Market, By Region

5.1.    Introduction

5.1.1.    Annual Growth Rate Comparison, By Region

5.1.2.    BPS Analysis, By Region

5.2.    Market Revenue (US$Mn) Forecast, By Region

5.2.1.    North America

5.2.2.    Latin America

5.2.3.    Europe

5.2.4.    Asia Pacific

5.2.5.    Middle East 

5.2.6.    Africa

5.3.    Global Clinical Trials Market Attractiveness Index, By Region

6.    North America Clinical Trials Market Analysis and Forecast, 2020–2028

6.1.    Introduction

6.1.1.    Annual Growth Rate Comparison, By Country

6.1.2.    BPS Analysis, By Country

6.2.    Market Revenue (US$Mn) Forecast, By Country

6.2.1.    U.S. Clinical Trials Market

6.2.2.    Canada Clinical Trials Market

6.3.    North America Clinical Trials Market, By Phase

6.3.1.    Phase 1

6.3.2.    Phase 2

6.3.3.    Phase 3

6.3.4.    Phase 4

6.4.    North America Clinical Trials Market, By Indication

6.4.1.    Oncology

6.4.2.    Pain Management

6.4.3.    Autoimmune Diseases

6.4.4.    CNS Diseases

6.4.5.    Obesity

6.4.6.    Diabetes

6.4.7.    Cardiovascular Diseases

6.4.8.    Others

6.5.    North America Clinical Trials Market Attractiveness Index

6.5.1.    By Country

6.5.2.    By Phase

6.5.3.    By Indication

7.    Latin America Clinical Trials Market Analysis and Forecast, 2020–2028

7.1.    Introduction

7.1.1.    Annual Growth Rate Comparison, By Country

7.1.2.    BPS Analysis, By Country

7.2.    Market Revenue (US$Mn) Forecast, By Country

7.2.1.    Brazil Clinical Trials Market

7.2.2.    Mexico Clinical Trials Market

7.2.3.    Argentina Clinical Trials Market

7.2.4.    Rest of Latin America Clinical Trials Market

7.3.    Latin America Clinical Trials Market, By Phase

7.3.1.    Phase 1

7.3.2.    Phase 2

7.3.3.    Phase 3

7.3.4.    Phase 4

7.4.    Latin America Clinical Trials Market, By Indication

7.4.1.    Oncology

7.4.2.    Pain Management

7.4.3.    Autoimmune Diseases

7.4.4.    CNS Diseases

7.4.5.    Obesity

7.4.6.    Diabetes

7.4.7.    Cardiovascular Diseases

7.4.8.    Others

7.5.    Latin America Clinical Trials Market Attractiveness Index

7.5.1.    By Country

7.5.2.    By Phase

7.5.3.    By Indication

8.    Europe Clinical Trials Market Analysis and Forecast, 2020–2028

8.1.    Introduction

8.1.1.    Annual Growth Rate Comparison, By Country

8.1.2.    BPS Analysis, By Country

8.2.    Market Revenue (US$Mn) Forecast, By Country

8.2.1.    U.K. Clinical Trials Market

8.2.2.    Germany Clinical Trials Market

8.2.3.    Italy Clinical Trials Market

8.2.4.    France Clinical Trials Market

8.2.5.    Spain Clinical Trials Market

8.2.6.    Russia Clinical Trials Market

8.2.7.    Poland Clinical Trials Market

8.2.8.    BENELUX Clinical Trials Market

8.2.9.    NORDIC Clinical Trials Market

8.2.10.    Rest of Europe Clinical Trials Market

8.3.    Europe Clinical Trials Market, By Phase

8.3.1.    Phase 1

8.3.2.    Phase 2

8.3.3.    Phase 3

8.3.4.    Phase 4

8.4.    Europe Clinical Trials Market, By Indication

8.4.1.    Oncology

8.4.2.    Pain Management

8.4.3.    Autoimmune Diseases

8.4.4.    CNS Diseases

8.4.5.    Obesity

8.4.6.    Diabetes

8.4.7.    Cardiovascular Diseases

8.4.8.    Others

8.5.    Europe Clinical Trials Market Attractiveness Index

8.5.1.    By Country

8.5.2.    By Phase

8.5.3.    By Indication

9.    Asia Pacific Clinical Trials Market Analysis and Forecast, 2020–2028

9.1.    Introduction

9.1.1.    Annual Growth Rate Comparison, By Country

9.1.2.    BPS Analysis, By Country

9.2.    Market Revenue (US$Mn) Forecast, By Country

9.2.1.    China Clinical Trials Market

9.2.2.    India Clinical Trials Market

9.2.3.    Japan Clinical Trials Market

9.2.4.    Australia And New Zealand Clinical Trials Market

9.2.5.    South Korea Clinical Trials Market

9.2.6.    ASEAN Clinical Trials Market

9.2.7.    Rest of Asia Pacific Clinical Trials Market

9.3.    Asia Pacific Clinical Trials Market, By Phase

9.3.1.    Phase 1

9.3.2.    Phase 2

9.3.3.    Phase 3

9.3.4.    Phase 4

9.4.    Asia Pacific Clinical Trials Market, By Indication

9.4.1.    Oncology

9.4.2.    Pain Management

9.4.3.    Autoimmune Diseases

9.4.4.    CNS Diseases

9.4.5.    Obesity

9.4.6.    Diabetes

9.4.7.    Cardiovascular Diseases

9.4.8.    Others

9.5.    Asia Pacific Clinical Trials Market Attractiveness Index

9.5.1.    By Country

9.5.2.    By Phase

9.5.3.    By Indication

10.    Middle East Clinical Trials Market, By Region

10.1.    Introduction

10.1.1.    Annual Growth Rate Comparison, By Country

10.1.2.    BPS Analysis, By Country

10.2.    Market Revenue (US$Mn) Forecast, By Country

10.2.1.    GCC Countries Clinical Trials Market

10.2.2.    Israel Clinical Trials Market

10.2.3.    Oman Clinical Trials Market

10.2.4.    Rest of Middle East Clinical Trials Market

10.3.    Middle East Clinical Trials Market, By Phase

10.3.1.    Phase 1

10.3.2.    Phase 2

10.3.3.    Phase 3

10.3.4.    Phase 4

10.4.    Middle East Clinical Trials Market, By Indication

10.4.1.    Oncology

10.4.2.    Pain Management

10.4.3.    Autoimmune Diseases

10.4.4.    CNS Diseases

10.4.5.    Obesity

10.4.6.    Diabetes

10.4.7.    Cardiovascular Diseases

10.4.8.    Others

10.5.    Middle East Clinical Trials Market Attractiveness Index

10.5.1.    By Country

10.5.2.    By Phase

10.5.3.    By Indication

11.    Africa Clinical Trials Market, By Region

11.1.    Introduction

11.1.1.    Annual Growth Rate Comparison, By Country

11.1.2.    BPS Analysis, By Country

11.2.    Market Revenue (US$Mn) Forecast, By Country

11.2.1.    South Africa Clinical Trials Market

11.2.2.    Egypt Clinical Trials Market

11.2.3.    North Africa Clinical Trials Market

11.2.4.    Rest of Africa Clinical Trials Market

11.3.    Africa Clinical Trials Market, By Phase

11.3.1.    Phase 1

11.3.2.    Phase 2

11.3.3.    Phase 3

11.3.4.    Phase 4

11.4.    Africa Clinical Trials Market, By Indication

11.4.1.    Oncology

11.4.2.    Pain Management

11.4.3.    Autoimmune Diseases

11.4.4.    CNS Diseases

11.4.5.    Obesity

11.4.6.    Diabetes

11.4.7.    Cardiovascular Diseases

11.4.8.    Others

11.5.    Africa Clinical Trials Market Attractiveness Index

11.5.1.    By Country

11.5.2.    By Phase

11.5.3.    By Indication

12.    Recommendation

12.1.    Market Strategy

13.    Competitive Landscape

13.1.    Competition Dashboard

13.2.    List and Company Overview of Global Key Players

13.3.    Company Profiles

13.3.1.    Quintiles IMS

13.3.1.1.    Company Overview

13.3.1.2.    Financial Overview

13.3.1.3.    Product Portfolio

13.3.1.4.    Key Developments

13.3.1.5.    Business Strategies

13.3.2.    Paraxel International Corporation

13.3.3.    Icon Plc

13.3.4.    Chiltern International Ltd.

13.3.5.    Bioclinica

13.3.6.    Medidata

13.3.7.    Bio – Optronics

13.3.8.    Sparta Systems

14.    Acronyms

Select License Type

Frequently Asked Questions

The clinical trials market in 2020 is accounted for more than US$ 45.3 Bn and expected to reach at a value of US$ 73.7 Bn by 2028 with a significant CAGR of 6.3%.

Unprecedented growth in pipeline activities of global pharmaceutical and biopharmaceutical companies drives the growth of global clinical trials market.

The global clinical trials market is segmented on the basis of phase, indication, and region.

Some of the key players identified in global clinical trials market are Quintiles IMS, Paraxel International Corporation, ICON PLC, Chiltern International Ltd., BIOCLINICA, MEDIDATA, BIO – OPTRONICS, SPARTA SYSTEMS etc. among others.



This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

OK